In fact, MSCs attracted myeloid-derived suppressor cells (MDSCs) in a C-C motif chemokine ligand 2 (CCL2)-dependent mechanism, hence lowering the activity of anti-cancer T cells even further (Lee et al., 2015). The gene discussed is CCL2; the disease is cancer.